MartinSebastianAllen-AuerbachMD
Nuclear Medicine • Los Angeles, CAAssociate Professor, Molecular & Medical Pharmacology, UCLA School of Medicine
Dr. Allen-Auerbach is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 Ucla Medical 365 Plz
Los Angeles, CA 90095Phone+1 310-794-1005Fax+1 310-267-0227- Is this information wrong?
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Nuclear Medicine, 2002 - 2003
New York Downtown HospitalResidency, Internal Medicine, 1999 - 2002
University of Vienna Faculty of MedicineClass of 1995
Certifications & Licensure
CA State Medical License 2002 - 2026- American Board of Nuclear Medicine Nuclear Medicine
Clinical Trials
Publications & Presentations
PubMed
- Visual and whole-body quantitative analyses ofGa-DOTATATE PET/CT for prognosis of outcome after PRRT withLu-DOTATATE.Masatoshi Hotta, Ida Sonni, Pan Thin, Kathleen Nguyen, Linda Gardner, Liliana Ciuca, Artineh Hayrapetian, Meredith Lewis, David Lubin, Martin Allen-Auerbach> ;Annals of Nuclear Medicine. 2024 Apr 1
- Differences and Common Ground inLu-PSMA Radioligand Therapy Practice Patterns: International Survey of 95 Theranostic Centers.Farolfi, A., Armstrong, W., Djaileb, L., Gafita, A., Hotta, M., Unterrainer, L., Fendler, W., Rettig, M., Eiber, M., Hofman, M., Hadaschik, B., Herrmann, K., Allen-Aue...> ;Journal of Nuclear Medicine. 2024 Mar 1
- PSMA PET/CT Dual-Time-Point Imaging: Nice to Have or Need to Have?Unterrainer, L., Ruchalski, K., Allen-Auerbach, M., Calais, J., Benz, M.> ;Journal of Nuclear Medicine. 2024 Jan 4
- Join now to see all
Press Mentions
UCLA Health Earns Comprehensive Center of Excellence Designation for Radiopharmaceutical Therapy as Work Continues on New FacilityJune 29th, 2022
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical TrialJune 1st, 2019
Other Languages
- German, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
